Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Ventyx Biosciences Inc shares valued at $2,019 were sold by Nuss John on Apr 02 ’25. At $1.07 per share, Nuss John sold 1,887 shares. The insider’s holdings dropped to 467,226 shares worth approximately $1.12 million following the completion of this transaction.
Also, Nuss John sold 21,119 shares, netting a total of over 49,841 in proceeds. Following the sale of shares at $2.36 each, the insider now holds 464,582 shares.
Before that, Nuss John had added 21,119 shares to its account. In a trade valued at $49,842, the Officer bought Ventyx Biosciences Inc shares for $2.36 each.
As published in a research note from Wells Fargo on March 12, 2024, Ventyx Biosciences Inc [VTYX] has been rated up from an Equal weight to an Overweight and the price target has been revised to $16 from $7. Analysts at Oppenheimer upgraded the stock from ‘”a Perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid March. As of November 07, 2023, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for VTYX. Earlier on November 07, 2023, Stifel downgraded its rating. Their new recommendation was “a Hold” for VTYX stock which previously was a “a Buy”.
Analyzing VTYX Stock Performance
On last trading session,, Ventyx Biosciences Inc [NASDAQ: VTYX] plunged -0.41% to $2.4. The stock’s lowest price that day was $2.24, but it reached a high of $2.4792 in the same session. During the last five days, there has been a surge of approximately 9.09%. Over the course of the year, Ventyx Biosciences Inc shares have dropped approximately -4.38%. Shares of the company reached a 52-week high of $2.75 on 06/10/25 and a 52-week low of $0.78 on 04/07/25.
Support And Resistance Levels for Ventyx Biosciences Inc (VTYX)
According to the 24-hour chart, there is a support level at 2.27, which, if violated, would cause prices to drop to 2.13. In the upper region, resistance lies at 2.51. The next price resistance is at 2.61. RSI (Relative Strength Index) is 60.34 on the 14-day chart, showing neutral technical sentiment.
Is Ventyx Biosciences Inc subject to short interest?
Stocks of Ventyx Biosciences Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.49 million shares to 6.74 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 7.22 million shares. A decline of -7.21% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.67 of the overall float, the days-to-cover ratio (short ratio) decline to 4.67.
Which companies own the most shares of Ventyx Biosciences Inc (VTYX)?
In terms of Ventyx Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 45 in the next 12 months, up nearly 1767.22% from the previous closing price of $2.41. Analysts anticipate Ventyx Biosciences Inc stock to reach 60 by 2025, with the lowest price target being 6. In spite of this, 8 analysts ranked Ventyx Biosciences Inc stock as Buy at the end of 2025.
